LSXLS telcom AG
3.940EUR0.00%Mkt Cap: 24.81M $P/E: 65.67

LS telcom AG provides software, IT system, hardware, planning, and consultancy services for optimal spectrum use worldwide. The company offers its products in the areas of spectrum policy, licensing, and management; spec…

HeadlineSourceTime
Older
OnVista
Wallstreet Online
Wallstreet Online
Finanzen.net
TradingView
boerse.de
TradingView
TradingView
AAriva
Börse Express
Can LS telcom AG (ETR:LSX) Performance Keep Up Given Its Mixed Bag Of Fundamentals?

LS telcom's (ETR:LSX) stock is up by 6.3% over the past three months. However, the company's financials look a bit...

Simply Wall St.
LS telcom (ETR:LSX) Shareholders Will Want The ROCE Trajectory To Continue

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Simply Wall St.
Heineken’s Strongbow adds NaviLens levels to packaging

The cider brand has added a high-contrast NaviLens QR code to its cans.

Packaging Gateway
3 firms to lay off hundreds of North Jersey-based employees

BioReference health, JPMorgan Chase and an Italian fashion retailer are making the job cuts amid market uncertainty

The Bergen Record
Novartis to acquire Tourmaline Bio for $1.4 billion

Novartis will acquire Tourmaline Bio for $48 per share, valuing the New York-based biopharmaceutical company at $1.4 billion on a fully diluted basis, the Swiss pharma giant said on Tuesday. Tourmaline is focused on developing pacibekitug, a promising targeted therapy with the potential to reduce systemic inflammation, as a treatment option for atherosclerotic cardiovascular disease, Novartis said in a statement. With the deal, Novartis will acquire a Phase III-ready asset that will complement its existing cardiovascular disease portfolio, it said.

Reuters